Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
18.21
-2.70 (-12.89%)
At close: Nov 6, 2025, 4:00 PM EST
18.25
+0.05 (0.25%)
After-hours: Nov 6, 2025, 6:27 PM EST
Dyne Therapeutics Market Cap
Dyne Therapeutics has a market cap or net worth of $2.59 billion as of November 6, 2025. Its market cap has decreased by -22.95% in one year.
Market Cap
2.59B
Enterprise Value
1.92B
1-Year Change
-22.95%
Ranking
Category
Stock Price
$18.21
Market Cap Chart
Since the IPO on September 17, 2020, Dyne Therapeutics's market cap has increased from $790.90M to $2.59B, an increase of 227.47%. That is a compound annual growth rate of 25.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 2.97B | 24.01% |
| Dec 31, 2024 | 2.40B | 193.72% |
| Dec 29, 2023 | 816.30M | 35.12% |
| Dec 30, 2022 | 604.12M | -0.31% |
| Dec 31, 2021 | 606.03M | -36.50% |
| Dec 31, 2020 | 954.35M | 20.67% |
| Sep 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 839.90B |
| Johnson & Johnson | 448.39B |
| AbbVie | 385.86B |
| UnitedHealth Group | 293.97B |
| AstraZeneca | 251.76B |
| Novartis AG | 240.29B |
| Abbott Laboratories | 216.14B |
| Merck & Co. | 213.54B |